Profiling of histamine H4 receptor agonists in native human monocytes

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 136-143

  Gschwandtner, M ^a,b   Koether, B ^a   Werfel, T ^a   Stark, H ^c   Gutzmer, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Universitatsklinik fur Dermatologie   (Austria)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

4 methylhistamine; clobenpropit; histamine; histamine H4 receptor; ST 1006; UR PI376; VUF8430

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; 1 [2 (AMIDINOTHIO)ETHYL]GUANIDINE; 4 METHYLHISTAMINE; CLOBENPROPIT; HISTAMINE AGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H4 RECEPTOR; INTERLEUKIN 12P70; RANITIDINE; ST 1006; UNCLASSIFIED DRUG; UR PI376; 1 ((5 CHLORO 1H INDOL 2 YL)CARBONYL) 4 METHYLPIPERAZINE; 1-((5-CHLORO-1H-INDOL-2-YL)CARBONYL)-4-METHYLPIPERAZINE; 4-METHYLHISTAMINE; ANTIHISTAMINIC AGENT; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; INDOLE DERIVATIVE; INTERLEUKIN 12; LIGAND; PIPERAZINE DERIVATIVE;

ARTICLE; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SUPERNATANT; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSFECTION; METABOLISM; SECRETION (PROCESS); ST-1006; UR-PI376; VUF8430;

4-METHYLHISTAMINE; CLOBENPROPIT; HISTAMINE; HISTAMINE H4 RECEPTOR; ST-1006; UR-PI376; VUF8430;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; HUMANS; INDOLES; INTERLEUKIN-12; LIGANDS; MONOCYTES; PIPERAZINES; RANITIDINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H2; TRANSFECTION;

EID: 84881646668     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12237     Document Type: Article

References (24)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK, (2002). Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J Leukoc Biol 72: 962-969.
3. Daly MJ, Humphray JM, Stables R, (1981). Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Br J Pharmacol 72: 49-54.
4. Dijkstra D, Stark H, Chazot PL, Shenton FC, Leurs R, Werfel T, et al. (2008). Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol 128: 1696-1703.
5. Engelhardt H, Smits RA, Leurs R, Haaksma E, de Esch IJ, (2009). A new generation of anti-histamines: histamine H4 receptor antagonists on their way to the clinic. Curr Opin Drug Discov Devel 12: 628-643.
6. Gschwandtner M, Bunk H, Kother B, Thurmond RL, Kietzmann M, Werfel T, et al. (2012). Histamine down-regulates IL-27 production in antigen-presenting cells. J Leukoc Biol 92: 21-29.
7. Gutzmer R, Diestel C, Mommert S, Kother B, Stark H, Wittmann M, et al. (2005). Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 174: 5224-5232.
8. Gutzmer R, Gschwandtner M, Rossbach K, Mommert S, Werfel T, Kietzmann M, et al. (2011). Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. Front Biosci (Schol Ed) 3: 985-994.
9. Igel P, Geyer R, Strasser A, Dove S, Seifert R, Buschauer A, (2009). Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists. J Med Chem 52: 6297-6313.
10. Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, et al. (2003). The first potente and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46: 3957-3960.
11. Kiss R, Keseru GM, (2012). Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 22: 205-221.
12. Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R, (2005). Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314: 1310-1321.
13. Lim HD, Smits RA, Bakker RA, van Dam CM, de Esch IJ, Leurs R, (2006). Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. J Med Chem 49: 6650-6651.
14. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K, (2000). Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 279: 615-620.
15. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S, (2000). Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275: 36781-36786.
16. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. (2002). IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790.
17. Reher TM, Neumann D, Buschauer A, Seifert R, (2012). Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. Biochem Pharmacol 84: 192-203.
18. Rosethorne EM, Charlton SJ, (2011). Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins. Mol Pharmacol 79: 749-757.
19. Sander K, Kottke T, Tanrikulu Y, Proschak E, Weizel L, Schneider EH, et al. (2009). 2,4-Diaminopyrimidines as histamine H4 receptor ligands-scaffold optimization and pharmacological characterization. Bioorg Med Chem 17: 7186-7196.
20. Seifert R, Schneider EH, Dove S, Brunskole I, Neumann D, Strasser A, et al. (2011). Paradoxical stimulatory effects of the 'standard' histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Mol Pharmacol 79: 631-638.
21. Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, et al. (2006). Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 74: 2831-2838.
22. Sterk GJ, van der Goot H, Timmerman H, (1986). The influence of guanidino and isothiourea groups in histaminergic compounds on H2-activity. Agents Actions 18: 137-140.
23. Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, et al. (2004). A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309: 404-413.
24. Wittmann M, Zwirner J, Larsson VA, Kirchhoff K, Begemann G, Kapp A, et al. (1999). C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol 162: 6763-6769.